BR112012025344A2 - "composição de cuidados bucais e utilização de uma fonte de íons citrato" - Google Patents

"composição de cuidados bucais e utilização de uma fonte de íons citrato"

Info

Publication number
BR112012025344A2
BR112012025344A2 BR112012025344A BR112012025344A BR112012025344A2 BR 112012025344 A2 BR112012025344 A2 BR 112012025344A2 BR 112012025344 A BR112012025344 A BR 112012025344A BR 112012025344 A BR112012025344 A BR 112012025344A BR 112012025344 A2 BR112012025344 A2 BR 112012025344A2
Authority
BR
Brazil
Prior art keywords
composition
oral care
source
citrate ions
citrate
Prior art date
Application number
BR112012025344A
Other languages
English (en)
Other versions
BR112012025344B1 (pt
Inventor
Katharine Green Alison
Elizabeth Scott Ann
Thomas Littlewood David
Gayle Brading Melanie
Golding Stephen
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112012025344A2 publication Critical patent/BR112012025344A2/pt
Publication of BR112012025344B1 publication Critical patent/BR112012025344B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

composição para cuidados orais. a presente invenção se refere a uma composição de cuidados orais que compreende um éster de alquila do ácido gálico e uma fonte de ions citrato, na qual a quantidade da fonte de íons citrato é de pelo menos 0,6% em peso (em peso total da fonte de íons citrato com base no peso total da composição de cuidados orais). a incorporação da fonte de íons citrato na composição suprime a degradação e/ou a descoloração do éster de alquila do ácido gálico na composição
BR112012025344-1A 2010-04-09 2011-04-05 Composição para cuidados orais BR112012025344B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10159444 2010-04-09
EP10159444.8 2010-04-09
PCT/EP2011/055275 WO2011124572A1 (en) 2010-04-09 2011-04-05 Oral care compositions

Publications (2)

Publication Number Publication Date
BR112012025344A2 true BR112012025344A2 (pt) 2021-07-06
BR112012025344B1 BR112012025344B1 (pt) 2021-10-13

Family

ID=42668342

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012025344-1A BR112012025344B1 (pt) 2010-04-09 2011-04-05 Composição para cuidados orais

Country Status (4)

Country Link
EP (1) EP2555828B1 (pt)
CN (1) CN102811770B (pt)
BR (1) BR112012025344B1 (pt)
WO (1) WO2011124572A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800007211A1 (it) * 2018-07-16 2020-01-16 Vittorio Pignatelli Composizioni dentifricie comprendenti curcumina

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB761186A (en) * 1953-08-06 1956-11-14 Eastman Kodak Co Antioxidant concentrates
GB824513A (en) * 1957-11-05 1959-12-02 Griffith Laboratories Improvements in or relating to antioxidant compositions and their preparation
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
FR2772042A1 (fr) * 1997-12-10 1999-06-11 Union Des Fabricants D Aliment Composition anti-oxydante, son procede de preparation et ses utilisations
EP1074245A3 (en) * 1999-08-06 2001-05-30 Sam Schwartz Composition using mineral salts for therapeutic treatment
JP4290819B2 (ja) 1999-09-14 2009-07-08 株式会社イーテック アスファルト乳化物及びその製造方法
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20070110683A1 (en) * 2005-11-16 2007-05-17 Gosmile, Inc. Oral care formulation
WO2008025468A1 (en) * 2006-08-31 2008-03-06 Dsm Ip Assets B.V. Oral care effervescent composition

Also Published As

Publication number Publication date
EP2555828A1 (en) 2013-02-13
BR112012025344B1 (pt) 2021-10-13
WO2011124572A1 (en) 2011-10-13
EP2555828B1 (en) 2017-07-19
CN102811770A (zh) 2012-12-05
CN102811770B (zh) 2014-07-09

Similar Documents

Publication Publication Date Title
BR112014009391A2 (pt) dosagem faseada de clopidogrel
BR112015014480A2 (pt) composições estáveis contendo íons metálicos
AR093792A1 (es) Composiciones que contienen zinc estables al fluoruro
DOP2013000252A (es) FORMULACION PARA ANTICUERPO ANTI-a4ß7
BR112015001618A2 (pt) composições fungicidas
BR112014018879A8 (pt) Composto e composição farmacêutica e combinação compreendendo dito composto
BR112015007131A2 (pt) métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética
BR112012018384A2 (pt) composição farmacêutica sólida com intensificadores e métodos de preparação da mesma.
BR112012021364A2 (pt) "compostos cicloalquila contendo tienopirimidinas e composições farmacêuticas".
BR112015018663A2 (pt) derivados de piridazinona-amidas
BRPI1103213B8 (pt) Composição de enxaguatório bucal antimicrobiano com teor alcoólico reduzido à base de óleo essencial bioativo
BRPI0606606A2 (pt) composições estáveis contendo prostaglandina
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
BR112014003903A2 (pt) composições dentais que compreendem agentes de adição fragmentação
BR112012024673A2 (pt) composição anestésica termogelificante
BR112016013194A2 (pt) Composições de higiene oral compreendendo carbonato de cálcio e sílica
BR112015023153A2 (pt) utilização de um composto e composto
BR112015011430A2 (pt) composição para liberação imediata e prolongada
BR112014025132A2 (pt) formulações de insulina
BR112015031878A2 (pt) composição farmacêutica
BR112013008173A2 (pt) composições cosméticas para o cuidado com a pele
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
BR112012019997A2 (pt) composições de cuidado oral
BR112014003640A2 (pt) métodos para perda de peso e composições cetogênicas
BR112015023387A2 (pt) composições lipídicas de racecodotril

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNILEVER IP HOLDINGS B.V. (PB)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/04/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2769 DE 30-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.